CenterBook Partners
VERA icon

CenterBook Partners’s Vera Therapeutics VERA Stock Holding History

CenterBook Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.69M Sell
52,308
-127,159
-71% -$4.45M 0.08% 324
2026
Q2 		$7.7M Buy
179,467
+82,464
+85% +$3.07M 0.38% 60
2026
Q1 		$3.9M Buy
97,003
+81,364
+520% +$3.51M 0.21% 124
2025
Q4 		$792K Buy
+15,639
New +$555K 0.04% 413

Other funds holding VERA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

CenterBook Partners's VERA Position: Q3 2026 in Review

CenterBook Partners reduced its Vera Therapeutics (VERA) stake by 71% in Q3 2026, selling an estimated $4.45M and leaving 52,308 shares worth $1.69M. The position accounts for 0.08% of the portfolio, ranked #324.

CenterBook Partners first reported a position in VERA in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.7M in Q2 2026. 49 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • CenterBook Partners held 52,308 shares of Vera Therapeutics worth $1.69M as of Q3 2026.
  • CenterBook Partners sold 127,159 Vera Therapeutics shares in Q3 2026, an estimated $4.45M.
  • Vera Therapeutics made up 0.08% of CenterBook Partners's portfolio in Q3 2026, its #324 holding.
  • CenterBook Partners first reported a position in Vera Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • CenterBook Partners's Vera Therapeutics position peaked at $7.7M in Q2 2026.
  • 49 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.